Newbridge Financial Services Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$309 Buy
+40
New +$292 ﹤0.01% 1119
2023
Q1
Sell
-1,500
Closed -$25.4K 1416
2022
Q4
$25.4K Sell
1,500
-1,000
-40% -$17.4K 0.01% 646
2022
Q3
$37K Sell
2,500
-64
-2% -$1.07K 0.02% 524
2022
Q2
$40K Sell
2,564
-500
-16% -$9.81K 0.02% 454
2022
Q1
$83K Sell
3,064
-850
-22% -$21.7K 0.04% 350
2021
Q4
$145K Sell
3,914
-200
-5% -$8.15K 0.07% 242
2021
Q3
$197K Buy
4,114
+3,850
+1,458% +$173K 0.12% 174
2021
Q2
$9K Hold
264
0.01% 1001
2021
Q1
$11K Sell
264
-329
-55% -$19.6K 0.01% 860
2020
Q4
$26K Buy
593
+500
+538% +$33.9K 0.02% 472
2020
Q3
$4K Buy
+93
New +$4.62K ﹤0.01% 831

Other funds holding ARCT